Intra-Abdominal Infection Treatment Market

Future Market Insights

Key Insight

The intra-abdominal infection treatment market is projected to grow from USD 26.9 billion in 2025 to USD 60.7 billion by 2035, at a CAGR of 8.5%. Antibiotics will dominate with a 35.0% market share, while staphylococcus will lead the pathogens - gram-positive segment with a 41.3% share.

September 15, 2025

Anurag Sharma

275 Pages

Cite this Report

Intra-Abdominal Infection Treatment Market

https://www.futuremarketinsights.com/reports/intra-abdominal-infection-treatment-market

License

Buy Now

Summary ToC Companies

Key Players

BlackRock
Bayer
Boehringer Ingelheim International GmbH
Bristol-Myers Squibb
Johnson & Johnson Services
Merck KGaA
Novartis
The Vanguard Group

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Intra-Abdominal Infection Treatment Market

Key Players

Similar Industry Reports